Cagrilintide
A long-acting amylin analog studied for its role in appetite regulation and metabolic research. Cagrilintide is researched for its effects on satiety, food intake, and body weight, alone and alongside GLP-1 compounds.
A new axis in metabolic research.
Cagrilintide is a long-acting synthetic analog of amylin, a hormone co-secreted with insulin from the pancreatic beta cells in response to food. Native amylin works alongside insulin to signal fullness and slow the pace of digestion; cagrilintide is engineered for extended stability, giving it a research profile suited to once-weekly study protocols.
Appetite and weight are rarely as simple as willpower, and women researching metabolic health increasingly recognize how much of the picture is hormonal. The satiety signals that tell the body it has had enough weaken and shift with age, stress, and metabolic load—the exact territory amylin research addresses.
Published research has documented cagrilintide’s role in reducing food intake and promoting satiety through amylin receptor activation, slowing gastric emptying, and—in combination with GLP-1 receptor agonists such as semaglutide—producing additive effects in body weight research. It has become one of the most closely watched compounds in the metabolic and appetite-regulation literature.
